RE:RE:Shorts increased by 507,470The Hedgies love to pick on the timid and hyper reactive shareholders of NASDAQ biotechs, and have the tools such as stop loss indicators to see how low they can cover. Naked Shorting is the norm. Other insti's are just as ruthless, I remember something similar with my Navidea (makers of Lymphoseek) stock years ago. The CEO took out a $80 MM loan with an investment bank that then shorted the stock and called in the loan. Last minute partnership deal with an upfront payment offered a short term reprieve. But shorts stick around like gum on your shoe and are masters at stock manipulation